Immunostep

CAR T cell therapy is based on the removal of T cells from the patient, the introduction of a specific Chimeric Antigen Receptor (CAR) of a protein present on cancer cells (e.g., CD19), and the subsequent reinfusion of these modified cells, now called CAR T cells, into the patient so that they recognize the target cells and eliminate them.

This therapy has become relevant due to its effectiveness, so CAR T cell detection tools have become a critical need, both to check that they have been modified correctly and to monitor them after reinfusion, since they have a limited shelf life.